Recommended purchasing channels and formal purchasing channels for mirikizumab

Mirikizumab is a new type of anti-IL-23 monoclonal antibody, mainly used to treat immune diseases such as moderately to severely active ulcerative colitis and psoriasis. Since the drug has not yet been officially approved for marketing in my country, patients who need to take the drug must purchase it through legal foreign channels. At present, the most reliable way is to assist patients to obtain overseas prescription drugs through formal cross-border drug service agencies or qualified international medical referral platforms, thereby ensuring that the sources of drugs are regular and transportation is compliant.

Abroad, Militizumab has been approved for marketing by the European Union and the United States drug regulatory agencies. The common specification is 300mg/15ml injection form. A box of the European version of the original drug sells for about more than 10,000 yuan. Patients may consider purchasing through channels that cooperate with large overseas pharmacies or hospitals, such as original drug direct supply platforms in countries such as Germany and Italy. Some platforms also provide Chinese and English bilingual services and international pharmacist consultation, which can help patients understand drug information, medication methods and precautions.

If you choose a purchasing agent or a third-party agency, be sure to confirm whether the other party has legal qualifications and provide complete drug purchase vouchers, invoices, drug batch numbers, import shipping documents and other information to prevent the purchase of counterfeit or substandard drugs. It is recommended to give priority to international medical cooperation platforms that have physical registration in China or are endorsed by third-party evaluations. Such platforms usually connect directly with foreign pharmaceutical companies or pharmacies, and their quality is relatively more guaranteed.

In short, although Militizumab is not currently available for direct purchase in domestic hospitals, the European version of the original drug can still be obtained through formal cross-border medical service channels. To ensure the safety of medication, patients should purchase and use it under the guidance of professional doctors. At the same time, they should avoid choosing informal or unqualified purchasing agents, beware of risks such as counterfeit medicines and wrong medicines, and ensure the continuity and efficacy of the treatment process.

Reference materials:https://www.drugs.com/